Literature DB >> 18826962

Functional alterations of the ubiquitin-proteasome system in motor neurons of a mouse model of familial amyotrophic lateral sclerosis.

Cristina Cheroni1, Marianna Marino, Massimo Tortarolo, Pietro Veglianese, Silvia De Biasi, Elena Fontana, Laura Vitellaro Zuccarello, Christa J Maynard, Nico P Dantuma, Caterina Bendotti.   

Abstract

In familial and sporadic amyotrophic lateral sclerosis (ALS) and in rodent models of the disease, alterations in the ubiquitin-proteasome system (UPS) may be responsible for the accumulation of potentially harmful ubiquitinated proteins, leading to motor neuron death. In the spinal cord of transgenic mice expressing the familial ALS superoxide dismutase 1 (SOD1) gene mutation G93A (SOD1G93A), we found a decrease in constitutive proteasome subunits during disease progression, as assessed by real-time PCR and immunohistochemistry. In parallel, an increased immunoproteasome expression was observed, which correlated with a local inflammatory response due to glial activation. These findings support the existence of proteasome modifications in ALS vulnerable tissues. To functionally investigate the UPS in ALS motor neurons in vivo, we crossed SOD1G93A mice with transgenic mice that express a fluorescently tagged reporter substrate of the UPS. In double-transgenic Ub(G76V)-GFP /SOD1G93A mice an increase in Ub(G76V)-GFP reporter, indicative of UPS impairment, was detectable in a few spinal motor neurons and not in reactive astrocytes or microglia, at symptomatic stage but not before symptoms onset. The levels of reporter transcript were unaltered, suggesting that the accumulation of Ub(G76V)-GFP was due to deficient reporter degradation. In some motor neurons the increase of Ub(G76V)-GFP was accompanied by the accumulation of ubiquitin and phosphorylated neurofilaments, both markers of ALS pathology. These data suggest that UPS impairment occurs in motor neurons of mutant SOD1-linked ALS mice and may play a role in the disease progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18826962      PMCID: PMC3298865          DOI: 10.1093/hmg/ddn319

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  52 in total

Review 1.  The 26S proteasome: a molecular machine designed for controlled proteolysis.

Authors:  D Voges; P Zwickl; W Baumeister
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

2.  Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis.

Authors:  J A Johnston; M J Dalton; M E Gurney; R R Kopito
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

Review 3.  Molecular biology of amyotrophic lateral sclerosis: insights from genetics.

Authors:  Piera Pasinelli; Robert H Brown
Journal:  Nat Rev Neurosci       Date:  2006-09       Impact factor: 34.870

4.  Tissue distribution of constitutive proteasomes, immunoproteasomes, and PA28 in rats.

Authors:  C Noda; N Tanahashi; N Shimbara; K B Hendil; K Tanaka
Journal:  Biochem Biophys Res Commun       Date:  2000-10-22       Impact factor: 3.575

5.  Assessing the role of immuno-proteasomes in a mouse model of familial ALS.

Authors:  Krishna Puttaparthi; Luc Van Kaer; Jeffrey L Elliott
Journal:  Exp Neurol       Date:  2007-03-30       Impact factor: 5.330

6.  Role of increased expression of the proteasome in the protective effects of sulforaphane against hydrogen peroxide-mediated cytotoxicity in murine neuroblastoma cells.

Authors:  Mi-Kyoung Kwak; Jeong-Min Cho; Bo Huang; Soona Shin; Thomas W Kensler
Journal:  Free Radic Biol Med       Date:  2007-05-31       Impact factor: 7.376

7.  Proteasomes remain intact, but show early focal alteration in their composition in a mouse model of amyotrophic lateral sclerosis.

Authors:  Edor Kabashi; Jeffrey N Agar; Yu Hong; David M Taylor; Sandra Minotti; Denise A Figlewicz; Heather D Durham
Journal:  J Neurochem       Date:  2008-06-01       Impact factor: 5.372

8.  Disease-associated prion protein oligomers inhibit the 26S proteasome.

Authors:  Mark Kristiansen; Pelagia Deriziotis; Derek E Dimcheff; Graham S Jackson; Huib Ovaa; Heike Naumann; Anthony R Clarke; Fijs W B van Leeuwen; Victoria Menéndez-Benito; Nico P Dantuma; John L Portis; John Collinge; Sarah J Tabrizi
Journal:  Mol Cell       Date:  2007-04-27       Impact factor: 17.970

9.  Insoluble mutant SOD1 is partly oligoubiquitinated in amyotrophic lateral sclerosis mice.

Authors:  Manuela Basso; Tania Massignan; Giuseppina Samengo; Cristina Cheroni; Silvia De Biasi; Mario Salmona; Caterina Bendotti; Valentina Bonetto
Journal:  J Biol Chem       Date:  2006-08-30       Impact factor: 5.157

10.  Depletion of 26S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies.

Authors:  Lynn Bedford; David Hay; Anny Devoy; Simon Paine; Des G Powe; Rashmi Seth; Trevor Gray; Ian Topham; Kevin Fone; Nooshin Rezvani; Maureen Mee; Tim Soane; Robert Layfield; Paul W Sheppard; Ted Ebendal; Dmitry Usoskin; James Lowe; R John Mayer
Journal:  J Neurosci       Date:  2008-08-13       Impact factor: 6.167

View more
  62 in total

Review 1.  Protein quality control during erythropoiesis and hemoglobin synthesis.

Authors:  Eugene Khandros; Mitchell J Weiss
Journal:  Hematol Oncol Clin North Am       Date:  2010-12       Impact factor: 3.722

2.  Accumulation of ubiquitin conjugates in a polyglutamine disease model occurs without global ubiquitin/proteasome system impairment.

Authors:  Christa J Maynard; Claudia Böttcher; Zaira Ortega; Ruben Smith; Bogdan I Florea; Miguel Díaz-Hernández; Patrik Brundin; Hermen S Overkleeft; Jia-Yi Li; Jose J Lucas; Nico P Dantuma
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-30       Impact factor: 11.205

3.  The Ubiquitin Receptor ADRM1 Modulates HAP40-Induced Proteasome Activity.

Authors:  Zih-Ning Huang; Lu-Shiun Her
Journal:  Mol Neurobiol       Date:  2016-11-05       Impact factor: 5.590

Review 4.  Role of ubiquitin-proteasome-mediated proteolysis in nervous system disease.

Authors:  Ashok N Hegde; Sudarshan C Upadhya
Journal:  Biochim Biophys Acta       Date:  2010-08-03

Review 5.  Walking the oxidative stress tightrope: a perspective from the naked mole-rat, the longest-living rodent.

Authors:  Karl A Rodriguez; Ewa Wywial; Viviana I Perez; Adriant J Lambert; Yael H Edrey; Kaitlyn N Lewis; Kelly Grimes; Merry L Lindsey; Martin D Brand; Rochelle Buffenstein
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

6.  A novel small molecule HSP90 inhibitor, NXD30001, differentially induces heat shock proteins in nervous tissue in culture and in vivo.

Authors:  Jieun R C Cha; Kyle J H St Louis; Miranda L Tradewell; Benoit J Gentil; Sandra Minotti; Zahara M Jaffer; Ruihong Chen; Allan E Rubenstein; Heather D Durham
Journal:  Cell Stress Chaperones       Date:  2013-10-03       Impact factor: 3.667

7.  Loss of ALS2/Alsin exacerbates motor dysfunction in a SOD1-expressing mouse ALS model by disturbing endolysosomal trafficking.

Authors:  Shinji Hadano; Asako Otomo; Ryota Kunita; Kyoko Suzuki-Utsunomiya; Akira Akatsuka; Masato Koike; Masashi Aoki; Yasuo Uchiyama; Yasuto Itoyama; Joh-E Ikeda
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

8.  Proteasome overload is a common stress factor in multiple forms of inherited retinal degeneration.

Authors:  Ekaterina S Lobanova; Stella Finkelstein; Nikolai P Skiba; Vadim Y Arshavsky
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

Review 9.  The importance of molecular histology to study glial influence on neurodegenerative disorders. Focus on recent developed single cell laser microdissection.

Authors:  Gerson Chadi; Jessica Ruivo Maximino; Gabriela Pintar de Oliveira
Journal:  J Mol Histol       Date:  2009-11-01       Impact factor: 2.611

Review 10.  Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond.

Authors:  Hristelina Ilieva; Magdalini Polymenidou; Don W Cleveland
Journal:  J Cell Biol       Date:  2009-12-14       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.